Intermittent oral cyclosporin for recurrent herpes simplex-associated erythema multiforme

Australasian Journal of Dermatology

Volumn 46, Issue 1, 2005, Pages 18-20

  Bakis, Sophie ^a   Zagarella, Samuel ^a  

^a Department of Microbiology and Infectious Diseases   (Australia)

Author keywords

Aciclovir; Herpes genitalis; Herpes labialis; Iminunosuppressive agents; Prednisone; Skin diseases; Treatment

Indexed keywords

ACICLOVIR; BETAMETHASONE DIPROPIONATE; CYCLOSPORIN; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; DRUG INTERMITTENT THERAPY; ERYTHEMA MULTIFORME; HERPES SIMPLEX; HUMAN; MALE; PAIN; RECURRENT DISEASE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; ERYTHEMA MULTIFORME; HERPES SIMPLEX; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; RECURRENCE;

EID: 14144255261     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2004.00130.x     Document Type: Article

References (19)

1. Drago F, Parodi A, Rebora A. Persistent erythema multiforme: report of two new cases and review of literature. J. Am. Acad. Dermatol. 1995; 33: 366-9.
2. Mahendran R, Grant JW, Norris PG. Dapsone-responsive persistent erythema multiforme. J. Dermatol. 2000; 200: 281-2.
3. Aurelian L, Ono F, Burnett J. Herpes simplex virus (HSV)-associated erythema multiforme (HAEM): a viral disease with an autoimmune component. Dermatol. Online J. 2003; 9 (1): 1.
4. Schofield JR, Tatnall FM, Leigh IM. Recurrent erythema multiforme: clinical features and treatment in a large series of patients. Br. J. Dermatol. 1993; 128: 542-5.
5. Bhushan M, Craven N. Erythema multiforme. In: Lebwohl M, Heymann WR, Berth-Jones J, Coulson I (eds). Treatment of Skin Disease: Comprehensive Therapeutic Strategies. London: Mosby, 2002; 196-9.
6. Huff JC. Erythema multiforme and latent herpes simplex infection. Semin. Dermatol. 1992; 11: 207-10.
7. Tatnall FM, Schofield JR, Leigh IM. A double-blind, placebo-controlled trial of continuous acyclovir therapy in recurrent erythema multiforme. Br. J. Dermatol. 1995; 132: 267-70.
8. Schofield JK, Tatnall FM, Brown J, McCloskey D, Navarrete C, Leigh IM. Recurrent erythema multiforme, tissue typing in a large series of patients. Br. J. Dermatol. 1994; 131: 532-5.
9. Kämpgen E, Burg G, Wank R. Association of herpes simplex virus-induced erythema multiforme with the human leukocyte antigen DQw3. Arch. Dermatol. 1988; 124: 1372-5.
10. Stampien TM, Schwartz RA. Erythema multiforme. Am. Fam. Physician 1992; 46: 1171-6.
11. Jones RR. Azathioprine therapy in the management of persistent erythema multiforme. Br. J. Dermatol. 1981; 105: 465-7.
12. Higgins CR, Schofield JR, Tatnall FM, Leigh IM. Natural history, management and complications of herpes labialis. J. Med. Virol. 1993; 1 (Suppl.): 22-6.
13. Lozada F. Levamisole in the treatment of erythema multiforme: a double-blind trial in fourteen patients. Oral Surg. Oral Med. Oral Path. 1982; 53: 28-31.
14. Chilukuri S, Rosen T. Management of acyclovir-resistant herpes simplex virus. Dermatol. Clin. 2003; 21: 311-20.
15. Rerob D, Assier-Bonnet H, Esnault-Gelly P, Blanc F, Saiag P. Recurrent erythema multiforme unresponsive to acyclovir prophylaxis and responsive to valacyclovir continuous therapy. Arch. Dermatol. 1998; 134: 876-7.
16. Wilkel CS, McDonald CJ. Cyclosporine therapy for bullous erythema multiforme. Arch. Dermatol. 1990; 126: 397-8.
17. Roo JYM, Lee CS, Maloney JE. Cyclosporine and related drugs. In: Wolverton SE (ed.). Comprehensive Dermatologic Drug Therapy. Philadelphia: WB Saunders, 2001; 205-29.
18. Callen JP, Camisa C. Antimalarial agents. In: Wolverton SE (ed.). Comprehensive Dermatologic Drug Therapy. Philadelphia: WB Saunders, 2001; 251-68.
19. Badalamenti S, Kerdel FA. Azathioprine. In: Wolverton SE (ed.). Comprehensive Dermatologic Drug Therapy. Philadelphia: WB Saunders, 2001; 165-79.